During re-biopsy, T790M is found in over half of the tumor samples taken from EGFR-TKI-resistant patients [3]; however, tumor re-biopsy is usually performed post tumor relapse, and is often not feasible in clinical situations such as those involving patients in poor physical condition and/or with hardly accessible target lesions. The gene discussed is EGFR; the disease is neoplasm.